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Retinitis pigmentosa (RP) is the most common inher-
ited retinal dystrophy, affecting approximately 1 in 5,000 
individuals worldwide [1,2]. RP primarily affects the rod 
photoreceptors, while the cone cells are compromised as the 
disease progresses [3]. Affected individuals exhibit night 
blindness in the initial stages of the disease followed by a 
progressive reduction in the visual field [3]. Ocular findings 
include atrophic changes in the photoreceptors and the RPE 
followed by the appearance of melanin-containing structures 
in the retinal vascular layer [3]. The fundus changes include 
a pale optic nerve, attenuation of the retinal vessels, and 
bone spicule-like pigmentation in the mid-peripheral retina 
[3]. Electroretinography (ERG) recordings show severely 
diminished or completely extinguished rod response while 
the cone response is somewhat normal in early stages but is 
undetectable as the disease progresses [3].
RP is a genetically heterogeneous disorder that mani-
fests as an autosomal dominant, autosomal recessive, and 
X-linked trait. To date, 73 genes have been implicated in the 
pathogenesis of RP. Of these genes, 27 have been associated 
with autosomal dominant RP (adRP) [4-30] while mutations 
in 50 genes have been identified in patients with autosomal 
recessive RP (arRP; RetNet) [31-77]. Interestingly, mutations 
in RHO (Gene ID: 6010; OMIM: 180380), RP1 (Gene ID: 
6101; OMIM: 603937), NRL (Gene ID: 4901; OMIM: 162080), 
RPE65 (Gene ID: 6121; OMIM: 180069), BEST1 (Gene ID: 
7439; OMIM: 607854), NR2E3 (Gene ID: 10002; OMIM: 
604485), IMPDH1 (Gene ID: 3614; OMIM: 146690) have 
been identified in familial cases of both adRP and arRP. 
Likewise, causal mutations in OFD1 (Gene ID: 8481; OMIM: 
300170), RP2 (Gene ID: 6102; OMIM: 300757), and RPGR 
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Loss of function mutations in RP1 are responsible for retinitis 
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Purpose: This study was undertaken to identify causal mutations responsible for autosomal recessive retinitis pigmen-
tosa (arRP) in consanguineous families.
Methods: Large consanguineous families were ascertained from the Punjab province of Pakistan. An ophthalmic 
examination consisting of a fundus evaluation and electroretinography (ERG) was completed, and small aliquots of 
blood were collected from all participating individuals. Genomic DNA was extracted from white blood cells, and a 
genome-wide linkage or a locus-specific exclusion analysis was completed with polymorphic short tandem repeats 
(STRs). Two-point logarithm of odds (LOD) scores were calculated, and all coding exons and exon–intron boundaries 
of RP1 were sequenced to identify the causal mutation.
Results: The ophthalmic examination showed that affected individuals in all families manifest cardinal symptoms 
of RP. Genome-wide scans localized the disease phenotype to chromosome 8q, a region harboring RP1, a gene previ-
ously implicated in the pathogenesis of RP. Sanger sequencing identified a homozygous single base deletion in exon 4: 
c.3697delT (p.S1233Pfs22*), a single base substitution in intron 3: c.787+1G>A (p.I263Nfs8*), a 2 bp duplication in exon 
2: c.551_552dupTA (p.Q185Yfs4*) and an 11,117 bp deletion that removes all three coding exons of RP1. These varia-
tions segregated with the disease phenotype within the respective families and were not present in ethnically matched 
control samples.
Conclusions: These results strongly suggest that these mutations in RP1 are responsible for the retinal phenotype in 
affected individuals of all four consanguineous families.
Correspondence to: S. Amer Riazuddin, Johns Hopkins University 
School of Medicine, 600 N. Wolfe Street; Maumenee 840, 
Baltimore, MD 21287; Phone: (410) 955-3656; FAX: (410) 955-3656; 
email: riazuddin@jhmi.edu
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(Gene ID: 6103; OMIM: 312610) have been identified in RP 
cases with an X-linked inheritance pattern [78-80].
RP1 was localized to chromosome 8q and consists of four 
exons that encode for a 2,156 amino acid protein [81]. Pierce 
and colleagues first identified mutations in RP1 responsible 
for adRP, and subsequently, they estimated that the nonsense 
mutation at codon 677 (p.R677*) is present in approximately 
3% of the dominant RP cases in North America [81]. The RP1 
protein localizes to the connecting cilia of the rod and cone 
cells in the ocular retina and is required for correct stacking 
of the outer segment disc [81,82].
Here, we report four consanguineous familial cases with 
multiple members who manifest cardinal symptoms of RP. 
Genome-wide linkage analyses localized the disease pheno-
type to chromosome 8q, harboring RP1, while bidirectional 
Sanger sequencing identified causal mutations in RP1 that 
segregated with the disease phenotype in their respective 
families and were absent in the ethnically matched controls 
and the genome-variant databases.
METHODS
Clinical ascertainment: More than 300 consanguineous Paki-
stani families with non-syndromic retinal dystrophies were 
recruited to identify new disease loci responsible for inherited 
visual diseases. The institutional review boards (IRBs) of the 
National Centre of Excellence in Molecular Biology (Lahore, 
Pakistan), the National Eye Institute (Bethesda, MD) and the 
Johns Hopkins University (Baltimore, MD) approved the 
study. All participating family members provided informed 
written consent that was endorsed by the respective IRBs and 
is consistent with the tenets of the Declaration of Helsinki.
A detailed clinical and medical history was obtained 
from the individual families. Funduscopy was performed 
at Layton Rehmatulla Benevolent Trust (LRBT) Hospital 
(Lahore, Pakistan). ERG measurements were recorded by 
using equipment manufactured by LKC (Gaithersburg, MD). 
Dark-adapted rod responses were determined through inci-
dent flash attenuated by −25 dB, whereas rod–cone responses 
were measured at 0 dB. The 30 Hz flicker responses were 
recorded at 0 dB to a background illumination of 17 to 34 
cd/m2.
All participating members voluntarily provided an 
approximately 10 ml blood sample that was stored in 
50 ml Sterilin® Falcon (Sarstedt, Inc. Newton, NC) tubes 
containing 400 μl of 0.5 M EDTA. Blood samples were stored 
at −20 °C for long-term storage.
Genomic DNA extraction: Genomic DNA was extracted from 
white blood cells using a non-organic modified procedure as 
described previously [83]. The concentration of the extracted 
genomic DNA was estimated with a SmartSpec plus Bio-Rad 
Spectrophotometer (Bio-Rad, Hercules, CA).
Genome-wide scan and exclusion analysis: The Applied 
Biosystems MD-10 linkage mapping panels (Applied Biosys-
tems, Foster City, CA) were used to complete a genome-wide 
scan for family PKRP117. PCR was completed in a 5 μl 
reaction volume containing 40 ng of genomic DNA, various 
combinations of 10 μM fluorescently labeled primer pairs, 
10X PCR buffer (100 mM Tris HCl pH 8.4, 400 mM NaCl, 
15 mM MgCl2, 2.5 mM Spermidine), 2 mM deoxynucleotide 
triphosphate (dNTP) mix, and 0.2 U OneTaq DNA poly-
merase (New England BioLabs Inc., Ipswich, MA). Initial 
denaturation was performed for 5 minutes (min) at 95 °C, 
followed by 10 cycles consisting of denaturation at 94 °C for 
15 s, annealing at 55 °C for 15 s and elongating at 72 °C for 
30 s, and then 20 cycles consisting of denaturation at 89 °C 
for 15 s, annealing at 55 °C for 15 s, and elongation at 72 
°C for 30 s. The final extension was performed for 10 min 
at 72 °C, followed by a final hold at 16 °C. PCR products 
were mixed with a loading cocktail containing HD-400 size 
standards (Applied Biosystems) and resolved in an Applied 
Biosystems 3100 DNA Analyzer. Genotypes were assigned 
using the Gene Mapper software from Applied Biosystems. 
Exclusion analyses were completed for PKRP262, PKRP344, 
and PKRP358 using closely spaced short tandem repeat 
(STR) markers.
Linkage analysis: Linkage analysis was performed with 
alleles of PKRP117 obtained through the genome-wide 
scan and the alleles of PKRP262, PKRP344, and PKRP358 
obtained through exclusion analysis using the FASTLINK 
version of MLINK from the LINKAGE Program Package 
[84,85]. Maximum LOD scores were calculated using ILINK 
from the LINKAGE Program Package. Autosomal recessive 
retinitis pigmentosa was investigated as a fully penetrant 
disorder that has an affected allele frequency of 0.001.
Mutation screening: The sequences of primer pairs used to 
amplify RP1 exons were designed using the Primer3 soft-
ware. The sequences of the primer pairs used for sequencing 
are shown in Appendix 1. PCR reactions were completed 
in 10 μl volume containing 20 ng of genomic DNA. PCR 
amplification consisted of a denaturation step at 95 °C for 5 
min followed by a two-step touchdown procedure. The first 
step of ten cycles consisted of denaturation at 95 °C for 30 s, 
followed by a primer set-specific annealing for 30 s (annealing 
temperature decreases by 1 °C per cycle) and elongation at 
72 °C for 45 s. The second step of 30 cycles consisted of dena-
turation at 95 °C for 30 s followed by annealing (annealing 
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temperature −10 °C) for 30 s and elongation at 72 °C for 45 s, 
followed by a final elongation at 72 °C for 5 min.
The PCR primers for each exon were used for bidirec-
tional sequencing using the BigDye Terminator Ready reac-
tion mix (Applied Biosystems, Foster City, CA), according 
to the manufacturer’s instructions. The sequencing products 
were resolved on an ABI PRISM 3100 DNA analyzer (Applied 
Biosystems), and results were analyzed with Applied Biosys-
tems SeqScape software.
In silico analysis: The degree of evolutionary conservation of 
the splice donor site (c.787+1G) in other RP1 orthologs was 
examined using the UCSC Genome Browser (Genome). The 
effect of the c.787+1G>A mutation on RP1 mRNA splicing 
was predicted with an online bioinformatics tool, the Human 
Splicing Finder 2.4.1 (HSF).
RESULTS
In an ongoing effort to investigate the genetic load of retinal 
dystrophies in the Pakistani population, we recruited a large 
cohort of familial cases with multiple members in these 
families manifesting cardinal symptoms of early onset RP. 
Among these families, PKRP117, PKRP262, PKRP344, and 
PKRP358 were recruited from the Punjab province of Paki-
stan. In PKRP117, we were able to enroll a total of 19 family 
members, including nine affected individuals (Figure 1A). A 
detailed medical history, including the onset and progression 
of the ocular disease, was obtained by interviewing family 
elders, especially the parents of the affected individuals, 
which revealed that all affected individuals complained of 
night blindness during the early years of their life. Exclusion 
analysis with closely spaced STR markers spanning known 
RP loci suggested linkage to chromosome 8q harboring RP1. 
Maximum two-point LOD scores of 3.21, 6.95, and 5.95 at 
θ = 0 were obtained with markers D8S1737, D8S509, and 
D8S2332, respectively (Table 1).
In parallel, we enrolled three affected and nine unaf-
fected members of PKRP262, four affected and three unaf-
fected members of PKRP344, and four affected and three 
unaffected members of PKRP358 (Figure 1B-D). Fundus 
photographs of the affected individuals revealed typical 
symptoms of RP, including attenuated retinal arteries, waxy, 
pale optic disc, and bone spicule-like pigment deposits in the 
lateral and mid-periphery of the retina (Figure 2). Likewise, 
Figure 1. Pedigree drawings with a haplotype formed from the alleles of chromosome 8q microsatellite markers. A: PKRP117. B: PKRP262. 
C: PKRP344. D: PKRP358. Alleles forming the risk haplotype are black, heterozygous alleles cosegregating with the phenotype are gray, 
and alleles not cosegregating with RP are shown in white. Square = male; circle = female; filled symbol = affected individual; the double 
line between individuals = consanguineous marriage; the diagonal line through a symbol = deceased family member.
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scotopic ERG recordings measured at −25 dB and photopic 
responses at 0 dB (30 Hz flicker) were undetectable in the 
affected individuals, suggestive of compromised rod photore-
ceptor and cone cells, while unaffected individuals exhibited 
rod and cone responses in the normal range (Figure 3).
Exclusion analysis localized all three familial cases 
(PKRP262, PKRP344, and PKRP358) to a region of chro-
mosome 8q harboring RP1. Alleles for markers D8S1737, 
D8S509, and D8S2332 yielded 2-point LOD scores of 2.54, 
2.51, and 2.51 at θ = 0 and 1.42, 2.13, and 2.52 at θ = 0 for 
families PKRP262 and PKRP358, respectively, while the 
alleles for markers D8S1737 and D8S509 yielded 2-point 
LOD scores of 1.62 and 1.15 at θ = 0 for PKRP344 (Table 1). 
Although these LOD scores are less than a 2-point LOD score 
of 3.0, which is traditionally considered sufficient for linkage, 
they are the maximum two-point LOD scores attainable by 
PKRP262, PKRP344, and PKRP358 and were considered 
worthy of further investigation because the known RP locus, 
RP1, was included in the region.
To identify the causal mutation responsible for the RP 
phenotype in these four families, we sequenced all coding 
exons and the exon–intron boundaries of RP1. In PKRP117, we 
identified a 1-bp homozygous deletion in exon 4, c.3697delT, 
that is predicted to result in a frameshift p.S1233Pfs22* 
(Figure 4A-C). Likewise, we identified a homozygous varia-
tion in intron 3, c.787+1G>A (p.I263Nfs8*), in PKRP262 that 
affects the conserved splice donor site (Figure 4D-F) and a 2 
bp duplication in exon 2, c.551_552dupTA (p.Q185Yfs4*), in 
PKRP344 (Figure 4G-I).
In PKRP358, PCR of all three coding exons of RP1 
did not yield any amplification products for the affected 
individuals while the genomic DNA of the unaffected indi-
viduals produced amplified products of the appropriate size. 
One plausible explanation is that the affected individuals of 
PKRP358 harbor a homozygous deletion that removes the 
coding region of RP1. We designed six primer pairs between 
exons 1 and 2 of RP1 and another six primer pairs down-
stream of RP1 using Primer3 software. The sequences are 
available upon request. Briefly, each primer pair was PCR-
amplified in a 10 μl reaction volume containing 20 ng of 
genomic DNA, 1 μl of 10X PCR buffer, 2 mM dNTP mix, 1 
μl of 10 μM forward and reverse primer, 500 mM Betaine, 
Figure 2. Fundus photographs of 
individuals with retinal dystrophy. 
A: OD and OS of individual 8 
(affected, 25 years) of PKRP262. 
B: OD and OS of individual 12 
(affected, 10 years) of PKRP262. 
C: OD and OS of individual 16 
(affected, 12 years) of PKRP358. 
Fundus photographs of affected 
individuals show bone spicule-like 
pigmentation in the mid-periphery 
of the retina, attenuated retinal 
arteriole, severe maculopathy, and 
disc pallor. OD = oculus dexter; OS 
= oculus sinister.
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700 mM Dimethyl sulfoxide (DMSO), and 0.2 U OneTaq 
DNA polymerase. The initial denaturation step was at 95 
°C for 5 min followed by a two-step touchdown procedure. 
The first step of 10 cycles consisted of denaturation at 95 °C 
for 30 s, followed by a 66 °C annealing for 30 s (annealing 
temperature decreased by 1 °C after every cycle) and elonga-
tion at 72 °C for 45 s. The second step of 25 cycles consisted 
of denaturation at 95 °C for 30 s followed by 56 °C annealing 
for 30 s and elongation at 72 °C for 45 s, followed by a final 
elongation at 72 °C for 5 min. The amplification pattern of 
these 12 primer pairs helped us identify a 11,117 bp deletion 
(chr8:55,531,690-55, 542, 807) that removes all three coding 
exons of RP1 (Figure 5A-C).
All four mutations segregated with the disease pheno-
type in their respective families. All affected individuals 
were homozygous for the mutant allele while unaffected 
individuals were either heterozygous carriers or homozygous 
for the wild-type allele. These mutations were absent in ethni-
cally matched control chromosomes and were not found in the 
1000 Genomes, the NHLBI Exome Sequencing Project, and 
the dbSNP databases.
The mutation identified in PKRP117, c.3697delT 
(p.S1233Pfs22*), is expected to produce a truncated protein 
lacking 903 amino acids of the C-terminal, while the 
transcript harboring the mutation identified in PKRP344, 
c.551_552dupTA (p.Q185Yfs4*), is expected to degrade 
through nonsense-mediated decay. Moreover, affected indi-
viduals in PKRP358 are believed to have no expression of 
RP1 due to the large deletion that removes all coding exons 
of RP1. Therefore, the respective mutations in PKRP117, 
PKRP344, and PKRP358 are likely to have caused the RP 
phenotype in these families. However, we sought additional 
evidence to strengthen the candidacy of the splice donor 
variation identified in PKRP262.
First, we examined the evolutionary conservation of 
c.787+1G and found that the +1G of the splice donor site 
is completely conserved in RP1 orthologs in general and 
mammals in particular (Appendix 2). Second, we evalu-
ated the effect of the c.787+1G>A variation on RP1 mRNA 
splicing using Human Splice Finder 2 (HSF2). The HSF2 
generated consensus values of 80.96 and 48.29 for the wild-
type (c.787+1G) and mutant (c.787+1A) nucleotides, respec-
tively. The predicted consensus value deviation of −32.67 for 
c.787+1G>A suggests that the loss of the wild-type splice site 
will result in the retention of intron 3 of RP1 (Figure 5D), 
resulting in a frame shift and eventually a premature stop 
codon (p.I263Nfs8*).
Figure 3. Electroretinography responses of individuals with retinal dystrophy. Stimulus conditions: scotopic 0 dB bright flashes elicit rod 
responses (left column of each pair) and photopic 0 dB, 30 Hz flicker elicits cone responses (right column of each pair). Responses are of A: 
OD and B: OS: individual 8 (affected, 25 years); C: OD and D: OS: individual 12 (affected, 10 years); E: OD and F: OS: individual 7 (unaf-
fected, 60 years) of PKRP262. Affected individuals exhibit non-detectable electroretinography responses whereas the unaffected individual 
exhibits normal a and b waves suggestive of normal rod and cone functions. OD = oculus dexter; OS = oculus sinister.
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DISCUSSION
We previously reported homozygous mutations responsible 
for arRP in three consanguineous familial cases that impli-
cated RP1 in the pathogenesis of arRP [48]. Here, we report 
four consanguineous families recruited from the Punjab 
province of Pakistan with multiple members who manifest 
cardinal symptoms of RP. Linkage analyses with closely 
spaced STR markers localized the linkage interval in all four 
families to chromosome 8q12.1, harboring RP1, while Sanger 
sequencing of RP1 identified mutations that segregate with 
the disease phenotype in their respective families and are 
predicted to produce truncated RP1 proteins.
A total of 55 mutations have been identified in RP1 asso-
ciated with RP in multiple ethnic populations [7,48,86-112]. 
37 result in adRP while 17 mutations are responsible for arRP 
and one mutation responsible for sporadic case. The majority 
of the mutations identified in RP1 are either nonsense codons 
or lead to premature termination of RP1. Nonsense mutations 
in mammalian genes generally lead to unstable mRNAs that 
are degraded by nonsense-mediated decay [113]. However, 
nonsense-mediated decay does not occur if the mutation is 
present in the last exon, and therefore, most of the reported 
mutations are expected to produce stable transcripts trans-
lated into truncated proteins.
Figure 4. Sequence chromato-
grams of RP1 variations identified 
in families PKRP117, PKRP262, 
and PKRP344. A: Unaffected 
individual 7 homozygous for the 
wild-type. B: Unaffected individual 
9 heterozygous. C: Affected indi-
vidual 10 of PKRP117 homozygous 
for a single base pair deletion: 
c.3697delT in exon 4 of RP1. D: 
Unaffected individual 14 homozy-
gous for the wild-type. E: Unaf-
fected individual 11 heterozygous 
carrier. F: Affected individual 12 
of PKRP262 homozygous for G to 
A transition in intron 3: c.787+1G 
>A. G: Control homozygous for 
the wild-type allele. H: Unaffected 
individual 9 heterozygous carrier. I: 
Affected individual 10 of PKRP344 
homozygous for 2 bp duplication in 
exon 2: c.551_552dupTA.
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The precise mechanism that dictates whether a single 
allele would be sufficient or whether a homozygous mutation 
would be required for manifestation of the disease phenotype 
is not yet completely understood and probably varies among 
different examples. Nonetheless, it is conceivable that varia-
tions resulting in a mutant protein with a deleterious effect 
would manifest as an autosomal dominant trait while func-
tionally null alleles would manifest as an autosomal recessive 
disease. We previously speculated that disruption of RP1 
within or immediately after the bifocal gene product (BIF) 
domain might result in a protein with a deleterious effect 
whereas truncation of RP1 before the BIF motif or within the 
terminal portion of the protein would result in a loss of RP1 
function [48].
More than 50 causal mutations have been identified 
in patients with adRP and arRP within the past decade, 
including our earlier observation (Table 2). As shown in 
Figure 6, pathogenic mutations in the heterozygous state in 
RP1 responsible for adRP seem to reside between amino acid 
residues 617–1551. In contrast, the homozygous mutations 
responsible for arRP cluster in two regions: first, between 
amino acids 193–736 and, second, between amino acids 
1243–1890 (Figure 6). Taken together, these data support 
our earlier speculation [48]: Truncation mutations especially 
in the central region (800–1,200) of RP1 that is structurally 
not well defined, produce mutant proteins with a deleterious 
effect while mutations close to the N- and C-terminals of 
RP1 (>600 or <1,600) produce loss of function of the mutant 
proteins.
Moreover, the regions that include amino acid residues 
600–750 and 1,250–1,550 include mutations that have been 
associated with both adRP and arRP, although no single 
mutation has been associated with both adRP and arRP. 
Thus, it is tempting to speculate that “zones” exist in RP1 
in which the nature of the mutation instead of its location in 
the polypeptide dictates the inheritance pattern. Additional 
functional investigations are required to define these zones 
and elucidate mechanistic details of mutations leading to the 
particular genetic trait.
APPENDIX 1. THE PRIMER SEQUENCES FOR THE 
AMPLIFICATION OF RP1.
To access the data, click or select the words “Appendix 1.”
APPENDIX 2. SEQUENCE ALIGNMENT OF THE 
EXON-INTRON JUNCTION ILLUSTRATING 
CONSERVATIONS OF SPLICE-DONOR SITE OF 
INTRON 3 OF RP1. THE C.787+1G SHOWN IN RED 
ARE FULLY CONSERVED IN RP1 ORTHOLOGS.
To access the data, click or select the words “Appendix 2.”
Figure 5. Identification of a splice 
donor site mutation in RP1. A: 
Illustration of the deletion break-
points that remove all three coding 
exons of RP1. B: Forward sequence 
chromatograms of bases flanking 
the homozygous deletion. C: 
Reverse sequence chromatograms 
of bases flanking the homozygous 
deletion. D: In silico analysis of the 
splice donor site mutation in RP1. 
The HSF2 algorithm predicted 
a consensus value (CV) of 80.96 
for the wild-type splice donor site 
(c.787+1G) and 48.29 (c.787+1A) 
for the mutant. The consensus 
value deviation of −32.67 suggests 
that the loss of the wild-type splice site will result in retention of intron 3 of RP1 resulting in a frame shift and eventually a premature stop 
codon (p.I263Nfs8*).
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